Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
Open Access
- 1 April 2020
- journal article
- research article
- Published by Academy of Managed Care Pharmacy in Journal of Managed Care & Specialty Pharmacy
- Vol. 26 (4), 400-406
- https://doi.org/10.18553/jmcp.2020.26.4.400
Abstract
DISCLOSURES: This study received unrestricted funding from the Pharmaceutical Research Manufacturers of America. The authors also do consulting, personally or through their employment, with numerous pharmaceutical manufacturers, payers, and other stakeholders with a general interest in this subject matter.Keywords
This publication has 26 references indexed in Scilit:
- Universal Public Finance of Tuberculosis Treatment in India: An Extended Cost‐Effectiveness AnalysisHealth Economics, 2014
- Personalized Medicine: Pricing and Reimbursement Policies as a Potential Barrier to Development and Adoption, Economics ofPublished by Elsevier BV ,2014
- Public finance of rotavirus vaccination in India and Ethiopia: An extended cost-effectiveness analysisVaccine, 2013
- The Value of Diagnostic Testing in Personalized MedicineForum for Health Economics and Policy, 2013
- Quantifying the Value of Personalized Medicines: Evidence from COX-2 InhibitorsForum for Health Economics and Policy, 2013
- Pilot evaluation of the text4baby mobile health programBMC Public Health, 2012
- The Option Value of InnovationForum for Health Economics and Policy, 2012
- How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer TherapiesHealth Affairs, 2012
- Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residentsHealth Economics, 2010
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesThe New England Journal of Medicine, 1977